CRH functions as a growth factor/cytokine in the skin
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
We tested the effect of CRH and related peptides in a large panel of human skin cells for growth factor/cytokine activities. In skin cells CRH action is mediated by CRH‐R1, a subject to posttranslational modification with expression of alternatively spliced isoforms. Activation of CRH‐R1 induced generation of both cAMP and IP3 in the majority of epidermal and dermal cells (except for normal keratinocytes and one melanoma line), indicating cell type‐dependent coupling to signal transduction pathways. Phenotypic effects on cell proliferation were however dependent on both cell type and nutrition conditions. Specifically, CRH stimulated dermal fibroblasts proliferation, by increasing transition from G 1/0 to the S phase, while in keratinocytes CRH inhibited cell proliferation. In normal and immortalized melanocytes CRH effect showed dichotomy and thus, it inhibited melanocyte proliferation in serum‐containing medium CRH through G 2 arrest, while serum free media led instead to CRH enhanced DNA synthesis (through increased transition from G 1/G 0 to S phase and decreased subG 1 signal, indicating DNA degradation). CRH also induced inhibition of early and late apoptosis in the same cells, demonstrated by analysis with the annexin V stains. Thus, CRH acts on epidermal melanocytes as a survival factor under the stress of starvation (anti‐apoptotic) as well as inhibitor of growth factors induced cell proliferation. In conclusion, CRH and related peptides can couple CRH‐R1 to any of diverse signal transduction pathways; they also regulate cell viability and proliferation in cell type and growth condition‐dependent manners. J.Cell.Physiol. © 2005 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579 · cited 1×
“2005 Wiley-Liss, Inc. Corticotropin releasing hormone (CRH) is a 41-amino acid peptide that coordinates those central responses to stress mediated by the hypothalamic-pituitary-adrenal (HPA) axis (Chrousos, 1995; Perrin and Vale, 1999; Hillhouse et al., 2002).”
BackgroundMelanin pigmentation in mammalian skin and its hormonal regulation
Slominski, A., Tobin, D. J., Shibahara, S., & Wortsman, J. (2004) · Physiological Reviews · doi:10.1152/physrev.00044.2003 · Cited by 2,015
Self-citationSlominski, A., Wortsman, J., Luger, T., Paus, R., & Solomon, S. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.979 · Cited by 776
Self-citationNeuroendocrinology of the Skin1
Slominski, A., & Wortsman, J. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.5.0410 · Cited by 727
Self-citationThe cutaneous serotoninergic/melatoninergic system: securing a place under the sun
Slominski, A., Wortsman, J., & Tobin, D. J. (2005) · The FASEB Journal · doi:10.1096/fj.04-2079rev · Cited by 402 · cited 7×
“Thus skin melanocytes treated with CRH responds with ACTH-mediated increases in cortisol production (Slominski et al., 2005b).”
BackgroundResultInfluentialSelf-citationCutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors
SLOMINSKI, A., WORTSMAN, J., PISARCHIK, A., ZBYTEK, B., LINTON, E. A., MAZURKIEWICZ, J. E., & WEI, E. T. (2001) · The FASEB Journal · doi:10.1096/fj.00-0850rev · Cited by 305 · cited 3×
“CRH and related peptides and the corresponding CRH-Rs are expressed in the skin in species and cell type associated manners (Slominski et al., 2001, 2003b, 2004a).”
BackgroundSelf-citationCRH stimulation of corticosteroids production in melanocytes is mediated by ACTH
Slominski, A., Zbytek, B., Szczesniewski, A., Semak, I., Kaminski, J., Sweatman, T., & Wortsman, J. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00519.2004 · Cited by 211
Self-citationCutaneous Expression of CRH and CRH‐R: Is There a “Skin Stress Response System?”
SLOMINSKI, A. T., BOTCHKAREV, V., CHOUDHRY, M., FAZAL, N., FECHNER, K., FURKERT, J., KRAUSE, E., ROLOFF, B., SAYEED, M., WEI, E., et al. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08686.x · Cited by 147
Self-citationCRH stimulates POMC activity and corticosterone production in dermal fibroblasts
Slominski, A., Zbytek, B., Semak, I., Sweatman, T., & Wortsman, J. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.01.014 · Cited by 143
Cited by
Slominski, A. T., Zmijewski, M. A., Skobowiat, C., Zbytek, B., Slominski, R. M., & Steketee, J. D. (2012) · Advances in Anatomy, Embryology and Cell Biology · doi:10.1007/978-3-642-19683-6 · Cited by 496
Self-citationSlominski (2012) · doi:10.1007/978-3-642-19683-6_1 · Cited by 461
Key role of CRF in the skin stress response system
Slominski, A. T., Zmijewski, M. A., Zbytek, B., Tobin, D. J., Theoharides, T. C., & Rivier, J. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1092 · Cited by 400
Self-citationWhat are melanocytes really doing all day long…?
Plonka, P. M., Passeron, T., Brenner, M., Tobin, D. J., Shibahara, S., Thomas, A., Slominski, A., Kadekaro, A. L., Hershkovitz, D., Peters, E., et al. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.00912.x · Cited by 297
Self-citationDifferential expression of HPA axis homolog in the skin
Slominski, A., Wortsman, J., Tuckey, R. C., & Paus, R. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.12.012 · Cited by 279
Self-citationCutaneous hypothalamic–pituitary–adrenal axis homolog: regulation by ultraviolet radiation
Skobowiat, C., Dowdy, J. C., Sayre, R. M., Tuckey, R. C., & Slominski, A. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00217.2011 · Cited by 269
Self-citationBrain-Skin Connection: Stress, Inflammation and Skin Aging
Chen, Y., & Lyga, J. (2014) · Inflammation & Allergy-Drug Targets · doi:10.2174/1871528113666140522104422 · Cited by 263
Corticotropin releasing hormone and the skin
Slominski, A. (2006) · Frontiers in bioscience · doi:10.2741/1966 · Cited by 157
“Specificity of the CRH effects was documented by the use of CRH-R1 antagonists antalarmin and alpha-helical-CRH-[9-41](59).”
MethodSelf-citationExtra-adrenal glucocorticoid biosynthesis: implications for autoimmune and inflammatory disorders
Slominski, R. M., Tuckey, R. C., Manna, P. R., Jetten, A. M., Postlethwaite, A., Raman, C., & Slominski, A. T. (2020) · Genes & Immunity · doi:10.1038/s41435-020-0096-6 · Cited by 155
Self-citationSlominski, A. T., Janjetovic, Z., Fuller, B. E., Zmijewski, M. A., Tuckey, R. C., Nguyen, M. N., Sweatman, T., Li, W., Zjawiony, J., Miller, D., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009907 · Cited by 149
Self-citationSlominski, A. T., Brożyna, A. A., Zmijewski, M. A., Jóźwicki, W., Jetten, A. M., Mason, R. S., Tuckey, R. C., & Elmets, C. A. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.3 · Cited by 136
Self-citationAssociation between Stress and the HPA Axis in the Atopic Dermatitis
Lin, T.-K., Zhong, L., & Santiago, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102131 · Cited by 127
“CRH also extends the melanocyte survival by suppressing apoptosis [62], but inhibits their proliferation.”
BackgroundSkin as an endocrine organ: implications for its function
Slominski, A., Wortsman, J., Paus, R., Elias, P. M., Tobin, D. J., & Feingold, K. R. (2008) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2008.04.004 · Cited by 116
“Overall, the additional non-endocrine-related actions of CRF and related peptides define these peptides as growth factors/pleiotropic cytokines that are capable of regulating proliferation, apoptosis, differentiation, and immune interactions in vivo [19,33].”
BackgroundSelf-citationSlominski, A. T., Kim, T.-K., Janjetovic, Z., Tuckey, R. C., Bieniek, R., Yue, J., Li, W., Chen, J., Nguyen, M. N., Tang, E. K. Y., et al. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00203.2010 · Cited by 113
“Human SKMEL-188 and hamster AbC1 melanoma cells were grown in Ham’s F10 supplemented with 5% CT-FBS and 1% antibiotics (59).”
MethodSelf-citationThe Melanocyte and the Epidermal Melanin Unit: An Expanded Concept
Nordlund, J. J. (2007) · Dermatologic Clinics · doi:10.1016/j.det.2007.04.001 · Cited by 109
Cutaneous glucocorticosteroidogenesis: securing local homeostasis and the skin integrity
Slominski, A. T., Manna, P. R., & Tuckey, R. C. (2014) · Experimental Dermatology · doi:10.1111/exd.12376 · Cited by 79
Slominski, A. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08958.x · Cited by 74
Self-citationAyyadurai, S., Gibson, A. J., D'Costa, S., Overman, E. L., Sommerville, L. J., Poopal, A. C., Mackey, E., Li, Y., & Moeser, A. J. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.2hi0317-088rr · Cited by 52
CRH inhibits NF-κB signaling in human melanocytes
Zbytek, B., Pfeffer, L. M., & Slominski, A. T. (2006) · Peptides · doi:10.1016/j.peptides.2006.07.017 · Cited by 45
Self-citationCRH mediates inflammation induced by lipopolysaccharide in human adult epidermal keratinocytes
Zbytek, B., & Slominski, A. T. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700607 · Cited by 40
Self-citationThe impact of stress on tumor growth: peripheral CRF mediates tumor-promoting effects of stress
Arranz, A., Venihaki, M., Mol, B., Androulidaki, A., Dermitzaki, E., Rassouli, O., Ripoll, J., Stathopoulos, E. N., Gomariz, R. P., Margioris, A. N., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-261 · Cited by 30
“Therefore using non malignant cells it has been shown that CRF stimulated dermal fibroblasts proliferation while it inhibited cell proliferation in keratinocytes [42].”
BackgroundResultReduced expression of CRH receptor type 1 in upper segment human myometrium during labour
Cong, B., Zhang, L., Gao, L., & Ni, X. (2009) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-7-43 · Cited by 27
Metadata
- Authors
- Slominski, A., Zbytek, B., Pisarchik, A., Slominski, R. M., Zmijewski, M. A., & Wortsman, J.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2005-10-21
- Volume
- 206
- Issue
- 3
- Pages
- 780-791
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2073423510
- Cited by
- 128
- References
- 9
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.